Parnax Lab Limited schedules board meeting on May 28, 2026, to approve Q4 and FY2026 audited financial results.
The meeting agenda includes consideration of standalone and consolidated IND-AS compliant results with auditor report.
Trading window for equity shares has been closed since April 1, 2026, and will reopen 48 hours after results declaration.